Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA margin is N/A as of Tuesday, October 6, 2026.
EBITDA MARGIN
N/A
Eikon Therapeutics, Inc. Common Stock
Market Cap
$410.91M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$408.14M
EBITDA Margin
39.39%
TTM Avg
8.38%
3Y Avg
8.38%
5Y Avg
8.38%
Market Cap
$411.99M
EBITDA Margin
-59.97%
TTM Avg
-74.12%
3Y Avg
-94.06%
5Y Avg
-94.06%
Market Cap
$408.54M
EBITDA Margin
-48.80%
TTM Avg
-44.09%
3Y Avg
-45.35%
5Y Avg
-45.35%
Market Cap
$392.24M
EBITDA Margin
-107.01%
TTM Avg
-86.79%
3Y Avg
-53.66%
5Y Avg
-431.14%
Market Cap
$428.93M
EBITDA Margin
-232.13%
TTM Avg
-495.69%
3Y Avg
-578.57%
5Y Avg
-532.48%
Market Cap
$389.14M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$431.90M
EBITDA Margin
-184.73%
TTM Avg
-138.06%
3Y Avg
-2467.18%
5Y Avg
-2497.88%
Market Cap
$441.36M
EBITDA Margin
-16.58%
TTM Avg
-87.69%
3Y Avg
-357.20%
5Y Avg
-653.36%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eikon Therapeutics, Inc. Common Stock (EIKN) | $410.91M | N/A | N/A | N/A | N/A |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $408.14M | 39.39% | 8.38% | 8.38% | 8.38% |
| Carlsmed, Inc. (CARL)vs › | $411.99M | -59.97% | -74.12% | -94.06% | -94.06% |
| Shoulder Innovations, Inc. (SI)vs › | $408.54M | -48.80% | -44.09% | -45.35% | -45.35% |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $392.24M | -107.01% | -86.79% | -53.66% | -431.14% |
| Editas Medicine, Inc. (EDIT)vs › | $428.93M | -232.13% | -495.69% | -578.57% | -532.48% |
| MapLight Therapeutics, Inc. (MPLT)vs › | $389.14M | N/A | N/A | N/A | N/A |
| Capricor Therapeutics, Inc. (CAPR)vs › | $431.90M | -184.73% | -138.06% | -2467.18% | -2497.88% |
| Assembly Biosciences, Inc. (ASMB)vs › | $441.36M | -16.58% | -87.69% | -357.20% | -653.36% |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $378.75M | -403.32% | -429.38% | -429.38% | -429.38% |
Gross Margin
0.0%
EBITDA Margin
N/A
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
